PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.75
ESG score 90-95% of FBIO's 60.20. Bill Ackman would demand clear ESG improvement catalysts.
54.36
Environmental score 1.1-1.2x FBIO's 51.29. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
57.83
Social score 90-95% of FBIO's 63.59. Bill Ackman would demand clear social improvement catalysts.
58.05
Governance score 80-90% of FBIO's 65.72. Walter Schloss would scrutinize management accountability and board independence.